Acetaminophen Completed Phase 2 Trials for Rejection, Transplant Treatment

Indications	Status	Purpose	Phase
DBCOND0030946 (Rejection, Transplant)	Completed	Treatment	2

clinicaltrials.gov Identifier	Title	Drugs
NCT00771875	Randomized Trial for Mixed Acute Rejection	Acetaminophen (DB00316) Antithymocyte immunoglobulin (rabbit) (DB00098) Bortezomib (DB00188) Diphenhydramine (DB01075) Methylprednisolone (DB00959) Rituximab (DB00073)